Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (61-70 of 373) with videos related to

Pageof 38
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Cobimetinib (GDC-0973, XL518)Hana Andrlová, Robert Zeiser, Frank Meiss
The New England Journal of Medicine|October 20, 2021
Ruxolitinib for Chronic Graft-versus-Host Disease. ReplyRobert Zeiser, Takanori Teshima, Franco Locatelli
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2015
Acute Graft-versus-Host Disease: Novel Biological InsightsTakanori Teshima, Pavan Reddy, Robert Zeiser
The New England Journal of Medicine|July 30, 2020
Ruxolitinib for Acute Graft-versus-Host Disease. ReplyRobert Zeiser, Nikolas von Bubnoff, Gérard Socié
Current Stem Cell Research & Therapy|January 29, 2008
Acute graft-versus-host disease-challenge for a broader application of allogeneic hematopoietic cell transplantationRobert Zeiser, Andreas Beilhack, Robert S Negrin
Blood|March 9, 2026
Immune-mediated side effects of cancer immunotherapiesLukas M Braun, Jarushka Naidoo, Robert Zeiser
Blood Reviews|December 13, 2023
A personalized, organ-based approach to the treatment of chronic steroid-refractory graft-versus-host diseaseHanaa Fatoum, Robert Zeiser, Shahrukh K Hashmi
Trends in Cancer|August 9, 2025
Clinical perspective and treatment of immune-related colitis after cancer immunotherapyLukas M Braun, Yunjie Lu, Robert Zeiser
Blood|February 14, 2018
B-cell targeting in chronic graft-versus-host diseaseRobert Zeiser, Stefanie Sarantopoulos, Bruce R Blazar
British Journal of Haematology|September 14, 2016
Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activationRobert Zeiser, Gerard Socié, Bruce R Blazar
Pageof 38

Showing results (61-70 of 373) with videos related to

Sort By:
Pageof 38
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Cobimetinib (GDC-0973, XL518)Hana Andrlová, Robert Zeiser, Frank Meiss
The New England Journal of Medicine|October 20, 2021
Ruxolitinib for Chronic Graft-versus-Host Disease. ReplyRobert Zeiser, Takanori Teshima, Franco Locatelli
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 11, 2015
Acute Graft-versus-Host Disease: Novel Biological InsightsTakanori Teshima, Pavan Reddy, Robert Zeiser
The New England Journal of Medicine|July 30, 2020
Ruxolitinib for Acute Graft-versus-Host Disease. ReplyRobert Zeiser, Nikolas von Bubnoff, Gérard Socié
Current Stem Cell Research & Therapy|January 29, 2008
Acute graft-versus-host disease-challenge for a broader application of allogeneic hematopoietic cell transplantationRobert Zeiser, Andreas Beilhack, Robert S Negrin
Blood|March 9, 2026
Immune-mediated side effects of cancer immunotherapiesLukas M Braun, Jarushka Naidoo, Robert Zeiser
Blood Reviews|December 13, 2023
A personalized, organ-based approach to the treatment of chronic steroid-refractory graft-versus-host diseaseHanaa Fatoum, Robert Zeiser, Shahrukh K Hashmi
Trends in Cancer|August 9, 2025
Clinical perspective and treatment of immune-related colitis after cancer immunotherapyLukas M Braun, Yunjie Lu, Robert Zeiser
Blood|February 14, 2018
B-cell targeting in chronic graft-versus-host diseaseRobert Zeiser, Stefanie Sarantopoulos, Bruce R Blazar
British Journal of Haematology|September 14, 2016
Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activationRobert Zeiser, Gerard Socié, Bruce R Blazar
Pageof 38